Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/29/2025

Management of Yellow Facial Discoloration After Iron Infusion

Immediate Management and Prevention

  • The European Society of Cardiology recommends ensuring proper IV line placement and care to avoid extravasation to prevent yellow facial discoloration after iron infusion 1
  • The American Society of Hematology suggests using slower infusion rates, as faster rates have been associated with a higher risk of reactions, and switching IV line to normal saline at keep-vein-open (KVO) rate to maintain access 2
  • The American Society of Hematology advises stopping the infusion immediately if facial yellowing is observed during administration, notifying the physician, and performing a physical assessment of the patient's symptoms 2

Clinical Evaluation and Long-term Management

  • The American Society of Hematology recommends determining if the discoloration is isolated or associated with other symptoms, and evaluating for signs of hypersensitivity reaction, moderate reaction, or severe reaction 3
  • The American Society of Hematology suggests documenting the reaction in the patient's medical record, informing the patient that the discoloration may persist for weeks to months but may gradually fade, and evaluating the need for alternative iron formulations for future treatments 4

Patient Education and Special Considerations

  • The American Society of Hematology advises advising patients to report any discoloration promptly during or after the infusion, and reassuring that skin staining, while cosmetically concerning, does not typically cause other health problems 2